1. Home
  2. GAME vs CVKD Comparison

GAME vs CVKD Comparison

Compare GAME & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAME
  • CVKD
  • Stock Information
  • Founded
  • GAME 2011
  • CVKD 2022
  • Country
  • GAME United States
  • CVKD United States
  • Employees
  • GAME N/A
  • CVKD N/A
  • Industry
  • GAME
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • GAME
  • CVKD Health Care
  • Exchange
  • GAME Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • GAME 74.8M
  • CVKD 29.5M
  • IPO Year
  • GAME 2009
  • CVKD 2023
  • Fundamental
  • Price
  • GAME $0.95
  • CVKD $10.54
  • Analyst Decision
  • GAME Strong Buy
  • CVKD Strong Buy
  • Analyst Count
  • GAME 3
  • CVKD 1
  • Target Price
  • GAME $3.67
  • CVKD $32.00
  • AVG Volume (30 Days)
  • GAME 25.6M
  • CVKD 27.7K
  • Earning Date
  • GAME 08-13-2025
  • CVKD 08-11-2025
  • Dividend Yield
  • GAME N/A
  • CVKD N/A
  • EPS Growth
  • GAME N/A
  • CVKD N/A
  • EPS
  • GAME N/A
  • CVKD N/A
  • Revenue
  • GAME $99,579,536.00
  • CVKD N/A
  • Revenue This Year
  • GAME $6.08
  • CVKD N/A
  • Revenue Next Year
  • GAME $21.94
  • CVKD N/A
  • P/E Ratio
  • GAME N/A
  • CVKD N/A
  • Revenue Growth
  • GAME 77.06
  • CVKD N/A
  • 52 Week Low
  • GAME $0.50
  • CVKD $5.70
  • 52 Week High
  • GAME $2.87
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • GAME 42.59
  • CVKD 37.37
  • Support Level
  • GAME $1.47
  • CVKD $11.25
  • Resistance Level
  • GAME $1.24
  • CVKD $11.88
  • Average True Range (ATR)
  • GAME 0.26
  • CVKD 0.77
  • MACD
  • GAME -0.10
  • CVKD -0.03
  • Stochastic Oscillator
  • GAME 0.02
  • CVKD 2.95

About GAME GameSquare Holdings Inc.

GameSquare Holdings Inc is engaged in revolutionizing the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. It's next generation media, entertainment, and technology helps creators and maximize their brand partners' return on investment. Its purpose-built platform provides marketing and creative services, offers data and analytics solutions, and amplifies awareness through FaZe Clan.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: